HemoSense

HemoSense develops, manufactures and sells easy-to-use, handheld blood coagulation monitoring systems for use by patients and healthcare professionals in the management of warfarin medication. Our product, the INRatio System, measures the patient’s blood clotting time to ensure that patients with a propensity to form clots are maintained within the therapeutic range with the proper dosage of oral anticoagulant therapy. The INRatio System is 510(k) cleared by the FDA for use by healthcare professionals as well as for patient self-testing, and is also CE marked in Europe. The INRatio System is targeted to both the professional, or point-of-care, market as well as the patient self-testing market, the latter being an opportunity that has emerged primarily following the establishment of Medicare reimbursement in 2002 for mechanical heart valve patients. Several European countries have also implemented national reimbursement coverage of home PT/INR testing for chronic warfarin patients, including Germany, the United Kingdom, Denmark and the Netherlands.

Contact Details: 651 River Oaks Parkway San Jose CA 95134 United States of America Tel: (877)436-6444 or (408)719-1393 Fax: (408)719-1184 Email: moreinfo@hemosense.com WWW: www.hemosense.com/

Loading...

BioNews Results for HemoSense:
Alverix names new president and CEO	Pharmaceutical Business Review:  Jul 18 2008 5:01AM Matching: hemosense
Alverix names new president and CEO	Datamonitor:  Jul 17 2008 10:00PM Matching: hemosense
Alverix Appoints James D. Merselis as President and CEO	Genetic Engineering News:  Jul 16 2008 3:50PM Matching: hemosense
High Growth Reported for the World Blood Banking & Blood Products Market	Sys-Con UK:  Jun 30 2008 7:45AM Matching: hemosense
High Growth Reported for the World Blood Banking & Blood Products Market	SkyNewswire.com:  Jun 29 2008 9:46PM Matching: hemosense
Promote your company here: BioNewsCast - Press Release Distribution	→View more HemoSense news.

HemoSense Patents:
US Patent No.	Title
6673622	Coagulation or lysis assays by measuring impedance
6066504	Coagulation or lysis assays using an electroactive species
6060323	Method and device for measuring blood coagulation or lysis by viscosity changes
6046051	Method and device for measuring blood coagulation or lysis by viscosity changes

HemoSense (HEM) Financial information Links from Barchart
HEM Quote from from Barchart.com
HEM Chart from from Barchart.com
HEM Profile from from Barchart.com
HEM Opinion from from Barchart.com
→View more HemoSense finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 354 times since April 2007, the link to the organisation's website has been followed 87 times

Recent Search Terms used to find this page: inr | hemosense patent | hemosense | hemosense | t | HEMOSENSE | hemosense use | measuring blood clotting wales | inverness INRatio | contact details for Hemosense INRatio in England | .

Search for more companies in San Jose

Search for more companies in CA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for HemoSense